Sex-specific differences in FABP-4 in relation to CRC are plausible, as sex differences have also been observed in the association between general obesity and CRC risk [39, 54], where stronger associations have usually been observed with BMI in men than in women. Here, FABP4 is linked to colorectal carcinoma.